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Abstract
Background: Rhamnolipids are potent biosurfactants with high potential for industrial applications. However,
rhamnolipids are currently produced with the opportunistic pathogen Pseudomonas aeruginosa during growth on
hydrophobic substrates such as plant oils. The heterologous production of rhamnolipids entails two essential
advantages: Disconnecting the rhamnolipid biosynthesis from the complex quorum sensing regulation and the
opportunity of avoiding pathogenic production strains, in particular P. aeruginosa. In addition, separation of
rhamnolipids from fatty acids is difficult and hence costly.
Results: Here, the metabolic engineering of a rhamnolipid producing Pseudomonas putida KT2440, a strain certified
as safety strain using glucose as carbon source to avoid cumbersome product purification, is reported. Notably, P.
putida KT2440 features almost no changes in growth rate and lag-phase in the presence of high concentrations of
rhamnolipids (> 90 g/L) in contrast to the industrially important bacteria Bacillus subtilis, Corynebacterium
glutamicum, and Escherichia coli. P. putida KT2440 expressing the rhlAB-genes from P. aeruginosa PAO1 produces
mono-rhamnolipids of P. aeruginosa PAO1 type (mainly C10:C10). The metabolic network was optimized in silico for
rhamnolipid synthesis from glucose. In addition, a first genetic optimization, the removal of polyhydroxyalkanoate
formation as competing pathway, was implemented. The final strain had production rates in the range of P.
aeruginosa PAO1 at yields of about 0.15 g/gglucose corresponding to 32% of the theoretical optimum. What’s more,
rhamnolipid production was independent from biomass formation, a trait that can be exploited for high
rhamnolipid production without high biomass formation.
Conclusions: A functional alternative to the pathogenic rhamnolipid producer P. aeruginosa was constructed and
characterized. P. putida KT24C1 pVLT31_rhlAB featured the highest yield and titer reported from heterologous
rhamnolipid producers with glucose as carbon source. Notably, rhamnolipid production was uncoupled from
biomass formation, which allows optimal distribution of resources towards rhamnolipid synthesis. The results are
discussed in the context of rational strain engineering by using the concepts of synthetic biology like chassis cells
and orthogonality, thereby avoiding the complex regulatory programs of rhamnolipid production existing in the
natural producer P. aeruginosa.
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Background
Rhamnolipids are biosurfactants with high industrial
potential. The possible applications are manifold, as
reviewed by Lang and Wullbrandt [1] and Maier and
Soberón-Chávez [2]. For example, rhamnolipids can be
used as detergents in washing agents due to their ten-
sio-active properties. They can also be used as emulsi-
fiers in the cosmetic and food industry [3,4].
Particularly, they present a good alternative to chemi-
cally synthesized detergents, because they are biodegrad-
able, show novel properties like antimicrobial effects
[5-7], and are produced from renewable resources.
Rhamnolipids are mainly produced by bacteria of the
genus Pseudomonas; with most reports focusing on
strains of the opportunistic pathogen P. aeruginosa.
Rhamnolipids are composed of one or two hydrophobic
b-hydroxy fatty acids, which are linked through a b-gly-
cosidic bond to one or two rhamnose molecules [8,9]
forming the hydrophilic moiety. According to the num-
ber of rhamnose moieties, mono- and di-rhamnolipids
are differentiated. The fatty acids alkyl chain length in P.
aeruginosa can vary from C8 to C14 [10]; the most abun-
dant species contains two b-hydroxy fatty acids with C10
chains [8]. The alkyl chains can also contain up to two
unsaturated C-C bonds [5].
The rhamnose moiety is synthesized from glucose-6-
phosphat in five consecutive enzymatic steps [11]. The
b-hydroxy fatty acids in turn originate from fatty acid
de novo synthesis [12]. Both metabolic pathways exist in
many Gram-negative bacteria; besides de novo fatty acid
synthesis, the rhamnose synthesis pathway provides
building blocks for lipopolysaccharides of the outer
membrane of these organisms [13,14].
The synthesis pathway of rhamnolipids consists of
three dedicated enzymatic reactions. In the first step
two activated b-hydroxy fatty acids are linked by RhlA,
the 3-hydroxyacyl-ACP (acyl carrier protein):3-hydro-
xyacyl-ACP O-3-hydroxyacyltransferase, to a dimer,
called 3-(3-hydroxyalkanoyloxy)alkanoate (HAA) [12,15].
Mono-rhamnolipids are produced by RhlB, the rhamno-
syltransferase I, by the condensation of HAA and
dTDP-L-rhamnose [16,17]. The rhamnosyltransferase II
(RhlC) adds another rhamnose moiety to the mono-
rhamnolipid resulting in a di-rhamnolipid [17] (Figure
1). Notably, RhlG, a b-hydroxyacyl-ACP:CoA (coenzyme
A) transacylase, previously associated with rhamnolipid
synthesis, is not required for rhamnolipid synthesis in
vitro [12,18]. The genes rhlA and rhlB are organized in
a single operon, while rhlC is localized in another region
of the P. aeruginosa genome and forms an operon with
a gene of unknown function.
In P. aeruginosa the expression of all three genes
involved in rhamnolipid synthesis is regulated by two
quorum sensing systems and is active when P.
aeruginosa is cultivated under phosphate or nitrogen
limiting conditions [6,19-21]. The s54 factor is respon-
sible for the expression of rhlAB under these condi-
tions [22]. LasI/R and RhlI/R are also regulating
transcription of many virulence factors [23].
P. aeruginosa has the highest rate of rhamnolipid pro-
duction on plant oils as sole energy and carbon source
[6,24]. The use of plant oils in industrial rhamnolipid
production is a major drawback, as rhamnolipids are
strong emulsifiers requiring elaborate and expensive
methods for product purification, including organic sol-
vent intensive extraction [20,25].
There are however approaches to produce rhamnoli-
pids in bacteria other than P. aeruginosa by heterolo-
gous gene expression. Recombinant rhamnolipid
production generally enables industrial important
advantages. They facilitate both disconnecting biosynth-
esis from the complex quorum sensing regulation and
the opportunity of avoiding pathogenic production
strains, in particular P. aeruginosa. A topical review on
rhamnolipid production by genetic engineering strate-
gies using P. aeruginosa rhl-genes is given by Toribio et
al. [26]. For example, Ochsner et al. [27] examined
rhamnolipid synthesis by recombinant P. fluorescens, P.
putida, P. oleovorans, and E. coli, which were equipped
with the rhlAB operon. Recombinant strains of P. fluor-
escens were able to produce 0.25 g/L, those of P. putida
0.6 g/L rhamnolipid. Active rhamnosyltransferase was
also synthesized in E. coli and P. oleovorans, but no
rhamnolipids were formed. Wang et al. [28] reported
that heterologous expression of the rhlAB genes in the
E. coli strains BL21 and TnERAB led to the formation
of rhamnolipids. Cabrera-Valladares et al. [29] also
examined the heterologous production of mono-rham-
nolipids in E. coli W3110. They constructed an E. coli
strain that expressed the P. aeruginosa operons rhlAB
and rmlBDAC. The latter encodes the dTDP-L-rham-
nose synthesis pathway. With glucose as sole carbon
source, they achieved a concentration of 120 mg/L
mono-rhamnolipid and were able to show that recombi-
nant production of mono-rhamnolipid in E. coli is lim-
ited by the availability of dTDP-L-rhamnose. Cha et al.
[30] examined the option of expressing rhlAB from P.
aeruginosa in P. putida. They were able to produce up
to 7.3 g/L rhamnolipid with a recombinant P. putida
strain, utilizing soybean oil as substrate. Another study
with soybean oil as carbon source was carried out by
Wang et al. [28]. They inserted the rhlAB genes into P.
aeruginosa PEER02 through transposon-mediated chro-
mosome integration; the resulting strain produced 1.8
g/L rhamnolipid. Cabrera-Valladares et al. [29] also
used a hydrophobic substance (oleic acid) as substrate
and detected 52 mg/L rhamnolipid with recombinant E.
coli HB101.
Wittgens et al. Microbial Cell Factories 2011, 10:80
http://www.microbialcellfactories.com/content/10/1/80
Page 2 of 17
In the present study, we designed, constructed, and
analyzed a mono-rhamnolipid producing P. putida
KT2440 that overcomes the outlined limitations of the
natural producer P. aeruginosa. The constructed strain
is devoid of pathogenicity factors [31] and complex cel-
lular regulation, and uses glucose as carbon source
thereby avoiding extensive downstream processing. The
results are discussed in the context of different
approaches of heterologous rhamnolipid production.
Results
High rhamnolipid resistance as prerequisite for the
production host
The non-pathogenic host for rhamnolipid production
from glucose has to withstand high rhamnolipid concen-
trations to sustain industrially relevant production titers.
The industrial workhorses E. coli, B. subtilis, and C. glu-
tamicum, as well as the closely related, but non-patho-
genic Pseudomonas, P. putida were tested for resistance
against di-rhamnolipids. Using a microbioreactor sys-
tem, the growth of the species was monitored (Figure 2)
in the presence of up to 90 g/L di-rhamnolipid (purity
of 95%).
The effect of rhamnolipids on Gram-positive C. gluta-
micum is dramatic, where concentrations of less than
100 mg reduce the rate of growth by 60% (Figure 2d). B.
subtilis on the other hand, being Gram-positive as well,
features only slightly decreased growth rates, while the
duration of the lag-phase increases significantly in the
presence of rhamnolipids (Figure 2b). B. subtilis secretes
lipases, which might be able to disassemble di-rhamnoli-
pid, by splitting off the fatty acids from the sugar
Figure 1 Rhamnolipid biosynthesis pathway in P. putida. All enzymatic steps required for the synthesis of essential precursors including
host-intrinsic enzymes and exogenous RhlA and RhlB are shown. *) Annotated in P. putida as XanA [31].
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molecules, reducing the toxic effect significantly. Then,
B. subtilis would be able to grow unaffected by the
rhamnolipids derived residues, explaining the elongated
lag-phase and the almost unimpaired growth rates. Pos-
sible candidates that might extracellularly digest rham-
nolipids are the enzymes lipoyl synthase (EC 2.8.1.8)
and triacylglycerol lipase (EC 3.1.1.3), being products of
lipA and lipB, respectively [32].
In contrast, Gram-negative species appear to be less
affected and can grow in the presence of highly con-
centrated rhamnolipids. At a concentration of 90 g/L
di-rhamnolipid E. coli only grows with half the growth
rate it features when growing in absence of rhamnoli-
pids (Figure 2e). Importantly, P. putida KT2440, certi-
fied as a safety strain [31,33] showed little change in
growth rate in dependence of rhamnolipid concentra-
tions as high as 90 g/L (data not shown). As this
strain is closely related to P. aeruginosa, contains both
necessary pathways for rhamnolipid precursor synth-
esis (i.e., de novo lipid synthesis and creation of acti-
vated rhamnose) [31], and grows with a very high rate
on glucose [34], P. putida KT2440 was chosen as host
for rhamnolipid production using glucose as carbon
source.
Figure 2 Toxicity studies with di-rhamnolipids using different bacteria. (a) Inhibiting effect of di-rhamnolipids on E. coli. Di-rhamnolipid
concentrations tested were 0 g/L (■), 5 g/L (▲), 10 g/L (♦), 25 g/L (□), 50 g/L (○), and 90 g/L (◊). (b) Inhibiting effect of di-rhamnolipids on B.
subtilis. Di-rhamnolipid concentrations tested were 0 mg/L (■), 2.5 mg/L (●), 5 mg/L (▲), 10 mg/L (♦), 25 mg/L (□), 50 mg/L (○), 75 mg/L (Δ), and
90 mg/L (◊). (c) Inhibiting effect of di-rhamnolipids on C. glutamicum. Di-rhamnolipid concentrations tested were 0 mg/L (■), 2.5 mg/L (●), 5
mg/L (▲), 10 mg/L (♦), 25 mg/L (□), 50 mg/L (○), 75 mg/L (Δ), and 90 mg/L (◊). (d) Growth rates resulting from toxicity experiments with B.
subtilis (■) and C. glutamicum (●). (e) Growth rates resulting from toxicity experiments with E. coli.
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Blueprint of an optimal metabolic network for
rhamnolipid production
Having the chassis, the design of a metabolic network
with high capacity for rhamnolipid synthesis in P.
putida, using flux balance analysis with the rate of
rhamnolipid production as linear programming objec-
tive, was in focus. The constraints of the metabolic net-
work were, besides its structure, the substrate uptake
rate, the rate of biomass formation, and the energetic
demand for cell maintenance.
The theoretically achievable yields of rhamnolipids on
industrial relevant substrates (glucose, sucrose, glycerol,
and fatty acids (here as example octanoate)) were esti-
mated. The computational results indicate that cell
growth should be minimized to achieve high rhamnoli-
pid yields (Figure 3). In simulations without growth and
no or low cell maintenance, rhamnolipid yields varied
only slightly between the two sugars and glycerol. The
choice of substrate had an effect during growth or high
cell maintenance metabolism. Specifically, sucrose and
glycerol simulations were superior to simulations with
glucose, as the glucose ABC-transporter requires one
molecule of ATP per glucose molecule transported,
while glycerol is transported via an ion channel by diffu-
sion [31,35]. P. putida does not feature a sucrose uptake
system, which therefore has to be established by simu-
lating a sucrose porin channel [36] present in some P.
syringae strains [37,38]. According adaptations of the
computational metabolic network yielded in a non-
cellular energy consuming sucrose uptake. In subse-
quently carried out simulations, octanoate enabled the
highest yield (Figure 3b). Assuming the presence of an
ACP-ligase [39], octanoate requires only activation by
CoA/ACP to form HAA (Figure 4), thereby avoiding
metabolically expensive de novo lipid synthesis. The
rhamnose moiety requires b-oxidation and gluconeo-
genic reactions.
Notably, in simulations with low growth rates and
maintenance metabolism, rhamnolipid yield on glycerol
equaled yields on sugars; with higher growth rate and
maintenance metabolism, the yield on glycerol equaled
the yield on octanoate. The observation that a more
reduced carbon substrate is not beneficial for rhamnoli-
pid production by non-growing cells suggests that under
these conditions a carbon limitation exists, while pro-
duction by growing cells can be energy limited. Glycerol
feeds into the central carbon metabolism at the level of
glyceraldehyde-3-phosphate and thus does not utilize
the pentose phosphate (PP) pathway, which wastes car-
bon via CO2 production (Figure 4). Glucose and sucrose
enter the central carbon metabolism via the Entner-
Doudoroff (ED) pathway. To supply the cell with the
necessary energy for maintenance (via redox cofactor
synthesis), the PP pathway was active, hence wasting
carbon via CO2 formation. In scenarios with very high
energy demand (i.e., high growth rates and/or high
maintenance metabolism), full oxidation via acetyl-CoA
and the tricarboxylic acid (TCA) cycle was observed,
Figure 3 Theoretical yields in rhamnolipid production with P. putida under different conditions. (a) Rhamnolipid yields on alternative
carbon substrates. The yields were calculated for zero growth (black bars), zero growth and 30 mmol ATP/(gCDW h) maintenance metabolism
(white bars), growth at a rate of 0.4 1/h with 30 mmol ATP/(gCDW h) maintenance metabolism (gray bars), and a growth rate of 0.8 1/h with 50
mmol/(gCDW h) maintenance metabolism (shaded bars). The substrate uptake rates were constrained to 120 mCmol/(gCDW h). (b) Rhamnolipid
production capacity depending on biomass formation and maintenance metabolism for alternative carbon substrates. The course of rhamnolipid
production for uptake of glucose (■), glycerol (●), sucrose (▲) and octanoate (♦) are displayed. The black curves display rhamnolipid production
in dependence on the rate of growth; grey dashed curves display rhamnolipid production in dependence of maintenance metabolism.
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again resulting in CO2 formation and concomitant lower
rhamnolipid yield. The theoretically high rhamnolipid
yield on octanoate is a result of the omitted reaction
from pyruvate to acetyl-CoA (via the pyruvate
dehydrogenase).
In summary, the carbon substrates used for rhamnoli-
pid production by P. aeruginosa are theoretically ideal
for achieving high yields of product. However, the
extensive product purification from a second, hydropho-
bic phase is not desirable. Therefore, the industrially
important carbon source glucose is preferred. It is desir-
able to produce rhamnolipids from glucose with a host
that has low maintenance requirements and forms no
side-products. Ideally, such a host allows production
during non-growth conditions, to maximize the yield of
product on substrate.
Having the carbon substrate defined, subsequent
simulations focused on a metabolic network that is
optimal for rhamnolipid production from glucose. Pos-
sible reaction candidates include glucose uptake and
glucose catabolism. The earlier via a newly introduced
phosphotransferase system to improve the stoichiome-
try of glucose uptake and the latter via an artificial
Embden-Meyerhof-Parnas (EMP) pathway by introdu-
cing a phosphofructokinase to improve ATP genera-
tion by substrate level phosphorylation, respectively.
Notably, the improvements of the tested scenarios
were minor (below 1% of additional rhamnolipid) again
highlighting that carbon and not energy availability
determines the yield of rhamnolipid production.
Hence, these optimizations were not considered as
valuable targets for the improvement of rhamnolipid
production. Instead, removing enzymatic reactions that
are not necessary for rhamnolipid production, but
potentially waste carbon moved into focus. As already
mentioned, no side products from central carbon
metabolism (e.g., carboxylic or amino acids) were
observed in the growth medium. Therefore, the avoid-
ance of biomass components that are not necessary for
survival and production are the only means for meta-
bolic optimization. One such target is the storage poly-
mer polyhydroxyalkanoate (PHA). In P. putida, PHA-
synthesis directly competes with the production of the
rhamnolipid precursor HAA (Figure 1). Eliminating
this reaction in vivo should lead to enhanced rhamno-
lipid yields. Choi et al. [40] recently showed in P. aeru-
ginosa PA14 and PAO1 ΔphaC1 mutants that indeed
PHA-production was lower. Again, after reaching a
defined concentration of cells in the media, which
suits rhamnolipid production best, biomass formation
should be deactivated or avoided to enable optimal
carbon exploitation.
Rhamnolipid production from glucose by non-pathogenic
P. putida
To enable the production of rhamnolipids in P. putida,
the essential genes for rhamnolipid production, located
in P. aeruginosa on the rhlAB operon (encoding RhlA
and RhlB) were introduced. The resulting recombinant
strain P. putida KT2440 pVLT33_rhlAB produced
mono-rhamnolipids (Figure 5). In comparison, P. aerugi-
nosa PAO1 produced mono- and di-rhamnolipids (Fig-
ure 5, lane 2). First quantification of rhamnolipids
indicated up to 0.35 g/L rhamnolipid in the P. aerugi-
nosa culture, and about 0.22 g/L mono-rhamnolipid in
the culture of the newly engineered P. putida KT2440
pVLT33_rhlAB.
The product spectrum of P. putida KT2440
pVLT33_rhlAB was investigated by HPLC-ESI-MS. The
results illustrated that the new strain produces rhamno-
lipids with fatty acids featuring chain lengths between
C8 and C12 in different combinations and in addition
very low amounts of rhamnolipids with C14 and C16
chains. Furthermore, some of the alkyl chains contained
one unsaturation. The most abundant rhamnolipid spe-
cies contained two fatty acids with C10 chains (Figure 6).
This was also the case for rhamnolipids that contained
only one b-hydroxy fatty acid chain. Although P. aerugi-
nosa and P. putida KT2440 pVLT33_rhlAB produced
rhamnolipids with different number of rhamnose resi-
dues, the produced rhamnolipids consisted of alkyl
chains with the same length. Hence, the production of
rhamnolipid with similar composition to the rhamnoli-
pid of P. aeruginosa (rhlC addition leads to di-rhamnoli-
pid synthesis) using glucose as carbon source was
achieved.
Figure 4 Scheme of utilized pathways during rhamnolipid
production by P. putida. ED, Entner-Doudoroff pathway; PP,
pentose phosphate pathway; PDC, pyruvate decarboxylation; G1P,
glucose-1-phosphate; HAA, b-D-(b-D-hydroxyalkanoyloxy)alkanoic
acid; RhlA, 3-hydroxyacyl-ACP:3-hydroxyacyl-ACP O-3-
hydroxyacyltransferase; RhlB, rhamnosyltransferase I.
Wittgens et al. Microbial Cell Factories 2011, 10:80
http://www.microbialcellfactories.com/content/10/1/80
Page 6 of 17
Rhamnolipid synthesis by a PHA-negative mutant
While it was shown that the engineered P. putida
KT2440 pVLT33_rhlAB produced rhamnolipids, the
yield on glucose was significantly below the theoretical
limit of 0.72 Cmolrhamnolipid/Cmolglucose (Figure 3). The
identified PHA production pathway was chosen as
potentially valuable target. P. putida uses b-hydroxyacyl-
ACP from de novo fatty acid synthesis as precursor for
PHA storage [41-43]. The b-hydroxyacyl-ACP is con-
verted to b-hydroxyacyl-CoA by PhaG b-hydroxyacyl-
ACP:CoA transacylase [44]. PhaC1 poly(3-hydroxyalka-
noic acid) synthase 1 catalyzes the reaction leading to
PHA [45]. As these reactions compete with formation of
hydroxyalkanoyl-alkanoates in the rhamnolipid synthesis
pathway, the use of a PhaC1-negative strain was chosen
as first optimization target. P. putida KT42C1 (ΔphaC1::
Kmr) [41], a derivative of P. putida KT2442 [46], was
tested as a host for rhamnolipid production. P. putida
KT2442 in turn is a spontaneous rifampicin resistant
mutant of P. putida KT2440. As the knockout was pro-
duced using a kanamycin resistance cassette, the rhlAB
operon was subcloned into the plasmid pVLT31, a
pVLT33 derivative carrying a tetracycline resistance.
The new strain P. putida KT42C1 pVLT31_rhlAB pro-
duced up to 1.5 g/L of rhamnolipid, about seven times
more than the original strain. The product profile of P.
putida KT42C1 pVLT31_rhlAB revealed that not only
mono-rhamnolipids, but also up to 20% of the free
hydroxy fatty acid was produced (Figure 7). To avoid
wasting of resources the formation of the hydroxy fatty
acids should be minimized. Therefore, future experi-
ments concentrate on the two alternative reactions
forming the free fatty acids: de novo synthesis or rham-
nolipid degradation. Also conceivable would be the
knocking out of the gene for the second poly(3-hydro-
xyalkanoic acid)synthase phaC2, which features minor
PHA-producing activities [41].
Uncoupling growth and rhamnolipid production: towards
minimal biomass formation
Ideally, to achieve optimal product yields, high production
rates without biomass formation are desirable. During the
fermentation, the growth rate of P. putida KT42C1
pVLT31_rhlAB declined (Figure 8). This growth behavior
on lysogeny broth (LB) medium was described for E. coli
Figure 5 Thin layer chromatography of rhamnolipids. The
sample of P. aeruginosa PAO1 (lane 2), grown in PPGAS-medium at
37°C, contains mono- and di-rhamnolipid as does the commercial
rhamnolipid (JBR425, Jeneil Biosurfactant Co.) (lane 1). P. putida,
expressing the rhlAB operon of P. aeruginosa from the plasmid
pVLT33_rhlAB, cultivated in glucose containing LB-medium
produced mono-rhamnolipid (lane 4). Empty vector control pVLT33
(lane 3). The band located above the di-rhamnolipids is IPTG (i.e.,
lanes 3 and 4).
Figure 6 Molecular structure of mono-rhamnolipids from
recombinant P. putida. The major compound (C10:C10) is indicated
by thick black lines, while minor compounds are indicated by thin
lines.
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and is explained by multiauxic growth due to sequential
compound uptake [47,48]. The kinetics underlying growth
of P. putida can best be described by a logistic growth for-
mulation (Equations (1) to (3)).
Although counterintuitive, changing growth rates did
not result in changing neither glucose uptake nor rham-
nolipid production rates (Figure 8). Importantly, the
constant rhamnolipid formation rate suggests that the
recombinant regulation of the rhamnolipid synthesis
operon cannot be influenced by the host and hence is
truly orthogonal during the growth and production
phases. Hence, rhamnolipids are produced from cells
that grow minimally or not at all, which opens opportu-
nities for long-term stable production with high product
yields (Figure 3). This is especially true, if glucose is the
carbon source for rhamnolipid production, while the
components of the LB medium are precursors for bio-
mass formation.
To elucidate if glucose primarily serves as substrate for
rhamnolipid production by P. putida KT42C1
pVLT31_rhlAB the use of glucose versus the use of alter-
native carbon sources was discriminated using uniformly
labeled 13C6-glucose in combination with appropriate ana-
lytics. A new custom-made off-gas sensor (BlueSens
GmbH, Herten, Germany) allowed the simultaneous quan-
tification of 12CO2 and
13CO2 concentrations. Assuming
that glucose is the carbon source for rhamnolipid produc-
tion, the conversion of pyruvate to acetyl-CoA (the mono-
mer of fatty acid polymerization) releases 13CO2.
The production of 13CO2 did not agree with time-
invariant glucose uptake and rhamnolipid production
rates, but rather a distinct and abrupt start of glucose
metabolization followed by a constant 13CO2 production
of 0.21-0.27 mmol/(gCDW h) (CDW: cell dry weight).
The specific production rate of 13CO2 remained con-
stant until glucose was depleted (Figure 9). The growth
and glucose uptake kinetics suggest that glucose meta-
bolism is suppressed by LB constituents, followed by
glucose catabolism after these constituents are depleted,
i.e., multiauxic growth [49]. Rhamnolipid production on
Figure 7 Percentage distribution of compounds gained by hydrophobic adsorption from the supernatant of a fermentation of P.
putida KT42C1 pVLT31_rhlAB.
Figure 8 Uncoupling of rhamnolipid production and cell
growth of P. putida in a 50 mL baffled flask. (a) Fermentation
characteristics including cell growth (■) and course of rhamnolipid
(▲) and glucose (♦) concentrations and their respective fitted
courses. CDW, cell dry weight. (b) Specific rates resulting from the
fitted experimental data. The black line represents the course of the
growth rate, while the dashed line and the dotted line show the
specific glucose uptake rate and the specific rhamnolipid
production rate respectively.
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glucose-complemented LB medium can be divided into
two phases, of which the first consists of rapid growth
on the most favored carbon substrates contained in the
LB medium, while the second phase is characterized by
a decreasing growth rate at constant specific glucose
uptake and rhamnolipid production rates, i.e., by gradual
uncoupling of biomass and rhamnolipid production.
The new off-gas sensor from BlueSens allowed to
rationalize these observed fermentation kinetics and
provided valuable insights into metabolic network
operation, which is of paramount importance for the
development of rhamnolipid production by P. putida
KT42C1 pVLT31_rhlAB under non-growth conditions.
Discussion
Comparison to P. aeruginosa wild type strains
Until now, rhamnolipid production mainly was carried
out by P. aeruginosa. In this work, a functional substitu-
tion to the opportunistic pathogenic, nosocomial P. aer-
uginosa, a non-pathogenic P. putida was developed. The
engineered strain has several advantages when compared
to rhamnolipid production with P. aeruginosa. We were
thus for instance able, to circumvent the complex
quorum sensing regulation in P. aeruginosa.
The achieved rhamnolipid production rate in the car-
ried out experiments amounted to two thirds of the rate
observed in optimized fermentations with P. aeruginosa
(Table 1). The obtained carbon yield also was in the
same range. For industrial production of rhamnolipids
the yield is an important parameter, as it determines the
expenses for the substrate. The rate of rhamnolipid pro-
duction might be raised by increasing activated rham-
nose availability as observed earlier [29]. Nevertheless,
the obtained rhamnolipid titer in the medium is still far
from the almost 40 g/L rhamnolipid reported with P.
aeruginosa [20], which can be explained by the low bio-
mass concentration in the described experiments. Fortu-
nately, P. putida is suited for high cell density
fermentations. While Kim et al. achieved 100 gCDW/L
with P. putida BM01 [50], even higher concentrations
were obtained with P. putida KT2442 [51]. In another
study, with P. putida KT2440, cell concentrations of up
to 62 gCDW/L were achieved [52].
An important improvement in comparison to the fer-
mentation of P. aeruginosa is the utilization of glucose
as substrate instead of hydrophobic substances such as
plant oils (despite the theoretical yield benefits) (Figure
3). Notably, the carbon yield of 0.23 Cmolrhamnolipid/
Cmolglucose on glucose here reported is 33% of the theo-
retical yield achievable on this substrate and in the same
order as the highest yield on oily carbon substrate
reported for P. aeruginosa (0.33 Cmolrhamnolipid/Cmolsoy-
bean oil) [53]. The main advantage nevertheless is that
purification of rhamnolipids from the fermentation
broth can be significantly simplified, as the surfactant
emulsifies the hydrophobic substrate in the P. aerugi-
nosa fermentation in the aqueous phase. Avoidance of
stable substrate/product emulsions using glucose as car-
bon source results in modest demands on sample pre-
paration for analytical procedures and more importantly
in reduced complexity of downstream processing.
Another benefit is that most bacteria grow faster with
glucose as carbon source than with fatty acids. Particu-
larly P. putida features a high growth rate when growing
on glucose [34]. Furthermore, glucose as carbon source
is a common substrate in biotechnological production
processes, which makes it notably cheaper than for
example soybean oil [54]. These advantages of glucose
as carbon source for rhamnolipid production outweigh
the downside that the theoretical yield is higher with
fatty acids as substrate.
Comparison to recombinant strains
The majority of experiments using recombinant bacteria
described so far utilize glucose as substrate for heterolo-
gous rhamnolipid production, while some reports with
Figure 9 Kinetics of rhamnolipid-production in P. putida in a
stirred 300 mL reactor. (a) Development of biomass (■) and
glucose (▲) concentrations. The experimental data is depicted by
symbols, while the lines present the fits using Equations (1) to (3).
CDW, cell dry weight. (b) Specific rates characterizing rhamnolipid
production in P. putida. The solid line presents the measured 13CO2
production rate originating from 13C-labeled glucose. The dashed
line represents the glucose uptake rate and was calculated from the
fitted glucose concentration curve. The dotted line shows the rate
of CO2 evolution, produced in the rhamnolipid synthesis pathway.
The curve was calculated from the experimentally determined yield
of rhamnolipid on glucose and the estimated rate of glucose
consumption.
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Table 1 Recombinant rhamnolipid production
Organism Medium Substrates Cell Dry
Weight
Carbon Yield1 Maximal
Titer
Process
Time
RL-Production
Rate
Space-Time
Yield
Specific RL-
Production Rate2
Reference
Substance [g/L] [gCDW/L] [Cmolrhamnolipid/
Cmolsubstrate]
[gRL/L] [h] [mgRL/(Lh)] [mgRL/(Lh)] [g/(gCDW h)]
P. aeruginosa
PAO1
MS Sunflower
Oil
250 16.3 0.07 39.00 90 16.67 433.33 0.027 Müller et al. 2010b [20]
P. putida KCTC
1067
MS Soybean
Oil
20 3.2 0.17 7.30 72 3.90 101.39 0.031 Cha et al. 2008 [30]
P. aeruginosa
PEER02
MS Soybean
Oil
20 not given 0.04 1.82 96 0.73 18.95 not calculable Wang et al. 2007 [28]
E. coli HB101 LB Oleic Acid 4 not given 0.01 0.05 24 0.08 2.18 not calculable Cabrera-Valladares et al.
2006 [29]
P. putida KT42C1 LB Glucose 10 2.0 0.23 1.50 42 1.37 35.71 0.018 This study
P. aeruginosa
PG201
GS Glycerol 20 not given 0.17 2.20 168 0.50 13.10 not calculable Ochsner et al. 1995 [27]
E. coli TnERAB LB Glucose 4 not given 0.07 0.18 24 0.28 7.30 not calculable Wang et al. 2007 [28]
P. aeruginosa
PEER02
MS Glucose 20 not given 0.06 0.79 96 0.31 8.18 not calculable Wang et al. 2007 [28]
P. putida KT2442 GS Glycerol 20 1.2 0.05 0.60 25 0.92 24.00 0.020 Ochsner et al. 1995 [27]
E. coli W3110 M9 Glucose 5 not given 0.04 0.12 48 0.10 2.51 not calculable Cabrera-Valladares et al.
2006 [29]
E. coli TnERAB MS Glucose 4 not given 0.03 0.08 24 0.12 3.15 not calculable Wang et al. 2007 [28]
P. fluorescens ATCC
15453
GS Glycerol 20 not given 0.02 0.25 168 0.06 1.49 not calculable Ochsner et al. 1995 [27]
E. coli DH5a M9 Glucose 5 not given < 0.01 < 0.02 168 0.00 0.06 not calculable Ochsner et al. 1995 [27]
P. oleovorans GPo1 GS Glycerol 20 not given 0.00 < 0.02 168 0.00 0.06 not calculable Ochsner et al. 1995 [27]
A comprehensive overview of production performance of recombinant strains is presented. For comparison, wild type P. aeruginosa PAO1 is listed in line 1. The next three lines show data from experiments with
hydrophobic substrates in contrast to the remaining entries. This data is based on hydrophilic substrate experiments.
1) For the calculation of yields during production on complex media, rhamnolipids were assumed to be synthesized from the used carbon source, while media compounds were utilized for cell growth. 2) The specific
rhamnolipid production rate was calculated as average over the whole fermentation time. LB, Lysogeny broth medium; MS, mineral salt medium; GS, nitrogen-limited minimal medium.
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hydrophobic substances exist (Table 1). Disregarding the
downsides accompanying the introduction of oily sub-
stances in the production process, these strains feature a
major advantage. Like the wild type strain P. aeruginosa
PAO1 they show higher titers than recombinant strains
using glucose as carbon source. However, probably due
to complex quorum sensing based regulation, these
strains need 1 to 3 days to reach the maximal titer. In
contrast, and partly also because sugars as carbon
source can be taken up and metabolized faster than
fatty acids most of the recombinant strains, which con-
stitute a serious alternative to P. aeruginosa using
hydrophilic substances as substrate reach the maximal
concentration of rhamnolipids in the medium after 1 to
2 days. This reduction in process time results in an
enhancement of the space-time yield. Notably, except P.
putida KCTC 1067 [30], the strain engineered in this
study features the highest reported space-time yield,
making it appropriate for further industrial development
of a biotechnological rhamnolipid production.
Comparing strain P. putida KT42C1 pVLT31_rhlAB
further to other attempts of recombinant rhamnolipid
production based on hydrophobic substrates, we
achieved a two to ten times higher titer (1.5 g/L), which
contributes to simplifying downstream processing and
entails reduction of investment costs as a smaller reactor
is required. The highest carbon yield reported with
recombinant strains by now was 0.17 Cmolrhamnolipid/
Cmolsubstrate [27,30]. The newly engineered strain P.
putida KT42C1 pVLT31_rhlAB had a comparatively
high yield of 0.23 Cmolrhamnolipid/Cmolsubstrate, which is
in the range of yields achieved with P. aeruginosa (0.33
Cmolrhamnolipid/Cmolsubstrate) [53].
Logistic growth
Logistic growth, as it can be observed in our experi-
ments (Figure 8) is based on population dynamics. This
model is applied in growth situations where the increase
in population size is limited by upper boundaries. The
general shape of a growth curve is sigmoidal, resulting
from zero growth at the beginning, increasing growth to
a maximal growth rate and subsequent decreasing
growth rates until an asymptote is reached. The logistic
model can be utilized to describe such courses. The
parameters incorporated in the equation on which logis-
tic growth is based upon resemble the biological para-
meters of the population. Parameters used are the initial
biomass concentration, the final biomass concentration,
the time after which half of the biomass is formed, and
furthermore a curve form coefficient, which has no
direct biological counterpart.
Growth of P. putida while producing rhamnolipids
can accurately be characterized via a logistic model, as
was shown for P. aeruginosa [55]. Having in mind the
phenomenon of multiauxic growth described earlier, it
could be that under the chosen cultivation conditions P.
putida is experiencing multiple, shifting limitations. One
can speculate that these growth-limits are determined
by the availability of the currently metabolized carbon
source, which changes frequently, when P. putida grows
on LB-medium supplemented with glucose. Again, the
significant reduction in growth is independent of rham-
nolipid production.
Conclusions
In this study, we successfully carried out mono-rhamno-
lipid synthesis by engineered P. putida. Featuring high
resistance against rhamnolipids, simple and controllable
production kinetics, and the metabolic ability to produce
rhamnolipids with high yield and rate, P. putida proved
to be an appropriate host for heterologous rhamnolipid
production.
The fermentation of non-pathogenic P. putida was
possible using glucose as substrate for the synthesis of
mono-rhamnolipids, while constituents of LB-medium
were the carbon sources for cell growth. By using quan-
titative fermentation kinetics monitoring including
advanced off-gas analysis we could show that rhamnoli-
pid production is uncoupled from biomass formation,
which offers possibilities for substrate exploitation and
process management.
In summary, an alternative, non-pathogenic host for
rhamnolipid production utilizing glucose as carbon
source was successfully developed. The insights into
rhamnolipid production with P. putida will contribute
to the further advance of this host; with the aim to
develop an industrially viable process. This study thus
adds to an increasing amount of literature regarding
industrial importance [56] and the applicability for het-
erologous expression of complex secondary metabolites
[57] of this bacterium.
Methods
Bacterial strains, culture conditions, and plasmids
The used bacteria strains Pseudomonas aeruginosa
PAO1 and Pseudomonas putida KT2440 [31,58] were
routinely cultivated in LB-medium (10 g/L tryptone, 5
g/L yeast extract, 10 g/L NaCl), while Escherichia coli
DH5a [59], Bacillus subtilis TEB1030 [32], and Coryne-
bacterium glutamicum ATCC 13032 [60] were culti-
vated in TB-medium (12 g/L tryptone, 24 g/L yeast
extract, 5 g/L glycerol, 12,54 g/L dipotassium phosphate,
2,31 g/L monopotassium phosphate). All bacteria were
cultivated at 37°C except P. putida and C. glutamicum,
which were grown at 30°C. P. putida and E. coli con-
taining the vector pVLT33 [61] and derivatives thereof
were selected by adding 50 μg/mL kanamycin to LB-
agar and liquid cultures. For selecting pVLT31 and
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derivates tetracycline with concentrations of 10 μg/mL
for recombinant E. coli and 20 μg/mL for recombinant
P. putida were added. Rhamnolipid production with P.
aeruginosa and recombinant P. putida was carried out
using LB-medium complemented with 10 g/L glucose.
Rhamnolipid toxicity determination
The experiments were carried out with a micro bioreac-
tor system (BioLector, m2p-labs GmbH, Baesweiler,
Germany), in 48 well plates (Flowerplates m2p-labs
GmbH, Baesweiler, Germany). The biomass concentra-
tion was quantified by online light scattering. All bac-
teria apart from P. putida KT2440 were cultivated in
800 to 1000 μL TB-medium. P. putida KT2440 was
grown in 500 μL LB-Medium supplemented with 10 g/L
glucose and 90 mM potassium phosphate buffer (pH
7.4). The growth medium contained rhamnolipid con-
centrations between 0 g/L and 90 g/L. The cultures
were shaken at 1,100 to 1,200 rpm (throw: 3 mm) and
incubated at 37°C or 30°C, for E. coli DH5a, B. subtilis
TEB1030, C. glutamicum ATCC13032, and P. putida
KT2440, respectively.
Construction of the rhamnolipid production module
The rhlAB operon was amplified from the genomic
DNA of P. aeruginosa PAO1 that was isolated with a
DNA isolation Kit (DNeasy Blood and Tissue Kit, QIA-
GEN, Hilden, Germany), using DNA polymerase (Pfu-
Turbo, Stratagene, Waldbronn, Germany) as described
by the supplier. The used primer had the following
sequences: sense 5’TTGAATTCCATCGGCTACGCGT-
GAACACGG’3, antisense 5’TTTTTCTAGATCAG-
GACGCAGCCTTCAGCC’3. The oligonucleotides were
obtained from Eurofins MWG Operon (Ebersberg, Ger-
many). The rhlAB PCR product was digested with
EcoRI/Acc65I and subsequently ligated into pVLT33,
which was digested with the same enzymes, creating the
plasmid pVLT33_rhlAB. Restriction enzymes and T4
DNA ligase were obtained from Fermentas (St. Leon-
Rot, Germany) and used as recommended. DNA manip-
ulation was carried out as described in Sambrook and
Russell [62]. Ligations were transformed into competent
E. coli DH5a using a standard protocol [59]. Trans-
formed cells were selected on LB-agar plates containing
50 μg/mL kanamycin. Experiments with the kanamycin
resistant single gene deletion strain P. putida KT42C1,
lacking the poly(3-hydroxyalkanoic acid) synthase 1
encoded by phaC1, required subcloning of rhlAB into
pVLT31, which contains a gene for tetracycline
resistance.
P. putida KT2440 was transformed using electropora-
tion as described by Choi et al. [63]. Cells containing
plasmid pVLT33 or the derivate pVLT33_rhlAB were
selected on LB-Agar plates or liquid cultures containing
50 μg/mL kanamycin. A resulting strain was denomi-
nated P. putida KT2440 pVLT33_rhlAB. This strain was
utilized for all further works.
Characterization of rhamnolipid production by P. putida
KT2440 pVLT33_rhlAB
For the production of rhamnolipids a main culture of 50
mL LB-medium supplemented with 10 g/L glucose and
50 μg/mL kanamycin in a 500 mL Erlenmeyer flask was
inoculated with 1 ml from a starter culture and incu-
bated at 30°C and 200 rpm (throw: 25 mm). The expres-
sion of rhl-genes was induced by adding IPTG
(isopropyl b-D-1-thiogalactopyranoside) to a final con-
centration of 0.4 mM (guaranteeing full induction) from
the beginning of the fermentation. Rhamnolipids were
extracted 24 h after induction.
P. aeruginosa was cultivated in 10 mL phosphate-lim-
ited protease peptone-glucose-ammonium salt medium
(PPGAS) at pH 7.2, which promotes the production of
rhamnolipids [64], containing 5 g/L glucose, 10 g/L pep-
tone 0.02 M NH4Cl, 0.02 M KCl, 0.12 M Tris-HCl, and
0.0016 M MgSO4. After 24 h at 37°C, with an agitation
of 150 rpm, rhamnolipids were harvested.
Cultivations of P. putida KT2440 pVLT33_rhlAB car-
ried out in order to supply rhamnolipid-characterization
via thin layer chromatography (TLC) and HPLC-ESI-MS
featured slightly different process parameters. Only 10
ml of LB-Medium, supplemented with 10 g/L glucose
and 50 μg/mL kanamycin in a 100 mL Erlenmeyer flask,
were inoculated with an OD580 of 0.05 from a starter
culture and incubated at 30°C and 150 rpm (throw: 25
mm). IPTG was added to a final concentration of 0.4
mM at an OD580 of 0.5.
To gain further insight into the fermentation kinetics
of rhamnolipid producing P. putida experiments in 300
mL bioreactors (RALF, Bioengineering AG, Wald, Swit-
zerland) were carried out. During 22 hours, the off-gas
was analyzed with an off-gas sensor (BlueSens GmbH,
Herten, Germany) applying dual wavelength infrared
light. This sensor facilitated the simultaneous quantifica-
tion of 12CO2 and
13CO2 concentrations in the off-gas.
The reactor was filled with 200 mL LB-medium comple-
mented with 10 g/L 100% labeled 13C6-glucose, IPTG to
a final concentration of 0.4 mM, and 20 μg/mL tetracy-
cline. The temperature was adjusted to 30°C and the
aeration rate to 12.1 NL/h. The stirrer speed was set to
500 rpm and after seven hours of fermentation
increased to 750 rpm.
The scale-up of rhamnolipid production was tested in
a 3.2-liter fermenter vessel (KLF 2000, Bioengineering
AG, Wald, Switzerland) with a working volume of 2
liters. The fermenter contained two 6-blade turbine stir-
rers, a temperature control, a pH control, and a gas
inlet. The operating conditions were set to pH 6.8 and a
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temperature of 30°C, a constant gassing rate of 0.5 vvm
and a stirrer speed in the range from 300 to 900 rpm
depending on the online-determined pO2 signal. Addi-
tional glucose was fed using a peristaltic pump.
Quantification of rhamnolipids
For analysis, rhamnolipids were extracted using 100 μL
for orcinol-assay and 500 μL for TLC respectively of
cell-free culture broth and 500 μL of ethyl acetate. Sam-
ples were mixed by vortexing, with a subsequent phase
separation by centrifugation in a tabletop centrifuge at
maximum speed (30 sec). The upper, rhamnolipid-con-
taining phase was transferred to a new reaction tube.
This procedure was repeated three times. Finally, the
organic solvent was removed by evaporation in a
vacuum centrifuge.
Thin layer chromatography of rhamnolipids
For detection of rhamnolipids using TLC, the dried
rhamnolipids were dissolved in 10 μL ethanol. 5 μL of
this solution were spotted on a silica 60 TLC-plate
(Macherey-Nagel, Düren, Germany). In addition, 5 μL of
a 0.1% commercial rhamnolipid extract (JBR425, Jeneil
Biosurfactant Co., LCC, Saukville, USA) containing
mono- and di-rhamnolipids was spotted. The running
buffer was a mixture of chloroform, methanol, and
acetic acid in a ratio of 65:15:2. To visualize the rham-
nolipids on the TLC-plates, the plates were covered
with a detection agent consisting of 0.15 g orcinol, 8.2
mL sulfuric acid (60%), and 42 mL deionized water. For
preservation, dried plates were incubated at 110°C for
10 min.
Rhamnolipid quantification using orcinol assay
The total amount of rhamnolipids was determined using
the orcinol assay [65,66]. The evaporated rhamnolipids
were dissolved in 100 μL deionized water. Subsequently
100 μL orcinol solution (1.6% orcinol in deionized
water) and 800 μL sulphuric acid (60%) were added.
The samples were incubated at 80°C for 30 min and
1000 rpm orbital shaking in a thermomixer (Eppendorf
AG, Hamburg, Germany). After cooling to room tem-
perature, the samples were measured at 421 nm in com-
parison to different concentrations of the commercial
rhamnolipid extract using a Genesys 10 UV spectro-
photometer (Thermo Fisher Scientific, Waltham, USA).
Rhamnolipid quantification using RP-HPLC-CAD
Reversed phase high performance liquid chromatogra-
phy corona charged aerosol detection (RP-HPLC-CAD)
was used for rhamnolipid quantification. Culture sam-
ples were centrifuged at 17,700 × g for 30 minutes. 100
μL supernatant were added to 900 μL deionized water,
mixed on a vortex shaker, and analyzed on a gradient
quaternary reversed phase HPLC system (LaChrom,
VWR- Hitachi, Darmstadt, Germany). The system was
equipped with an integrated C8(2) silica based column
(Luna C8(2), 4.6 × 150 mm, 5 μ, 100 Å, Phenomenex,
Inc. Torrance, CA, USA) and a corona CAD (ESA Bios-
ciences Inc., MA, USA). The sample volume was set to
20 μL. The sample was eluted at a flow rate of 800 μL
per minute and the temperature of the column oven
was set to 40°C. The mobile phase contained filtered
water with 0.4% trifluoracetic acid (TFA) (solvent A),
acetonitrile (solvent B), and methanol with 0.2% TFA
(solvent C) in different ratios. The method started with
20:0:80 (Vol.-% of solvent A:Vol.-% of solvent B:Vol.-%
of solvent C) and switched at 7.5 minutes to 2:18:80
during 2 minutes. After 20.6 minutes, the starting con-
centration was reestablished, again during 2 minutes.
The method ended after 24.6 minutes.
Rhamnolipid composition characterization by HPLC-ESI-MS
High performance liquid chromatography electrospray
ionization mass spectrometry (HPLC-ESI-MS) was used
for rhamnolipid characterization (Central Division of
Analytical Chemistry/BioSpec, Forschungszentrum
Jülich, Jülich, Germany). Rhamnolipids were extracted
from 1 L culture broth (5 L Erlenmeyer flask) as
described by Déziel et al. [8] with small modifications.
Cells were removed by centrifugation for 30 min at
9,000 × g and 10°C. The supernatant was acidified with
37% HCL to a pH of 3 and incubated overnight at 4°C.
The precipitated rhamnolipids were recovered by centri-
fugation (9,000 × g, 45 min, 4°C) and resuspended in 15
mL acidified water (pH 3). This suspension was
extracted three times with 15 mL ethyl acetate. The
combined organic phases were evaporated in a vacuum
centrifuge. The residue was dissolved in 15 mL of 0.05
M NaHCO3, acidified to pH 2 with 37% HCl, and incu-
bated overnight at 4°C. The precipitate was finally
recovered by centrifugation for 60 min at 13,000 × g
and 4°C.
For characterization, a binary HPLC system (Agilent
1100 series, Agilent Technologies, Waldbronn, Ger-
many), assembled with a diode array detector (DAD)
(190-400 nm), coupled with a triple quadrupole mass
spectrometer (4000QTRAP™, Applied Biosystem/MDS
SCIEX, Foster City, CA, USA) assembled with a turbo
ion spray source was used.
For rhamnolipid separation, normal phase chromato-
graphy was used with column dimensions of 150 × 2
mm i.d., 3 μm particle size (ProntoSIL 120-C8-SH, Bis-
choff Chromatography, Leonberg, Germany) at 20°C.
The gradient elution was done with deionized water
with 0.1% formic acid (solvent A) followed by different
concentrations of acetonitrile with 0.1% formic acid (sol-
vent B). The elution started with 60% B isocratic for 4
min, from 4 to 24 min a linear increase from 60% B to
90% B was applied, subsequently followed by a second
isocratic step (90% B for 10 min), and ended by a return
to 60% B in one min. The re-equilibration was done
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with 60% B isocratic for 10 min. All steps were per-
formed at a constant flow rate of 300 μL/min. The
injection volume was 20 μL.
The MS was used in negative enhanced mass spec-
trum mode scanning from 200 - 1000 Da. A flow injec-
tion analysis with a standard was used at first to
optimize the following parameters: IS -4500 V, declus-
tering potential -100 V, curtain gas (N2) 10 arbitrary
units (au), source temperature 500°C, nebulizer gas (N2)
50 au, and heater gas (N2) 20 au. Collision energy (CE)
and third quadrupole-entry barrier were set to -5 V and
8 V, respectively. The negative enhanced product ion
scan mode was used for structural elucidation MS/MS
experiments, in which product ions are generated in the
second quadrupole by collision-activated dissociation of
selected precursor ions of the first quadrupole and mass
analyzed in a linear ion trap. The CE ranged from 30 to
70 V.
The di-rhamnolipid standard (Rha-Rha-C10-C10) for
HPLC analysis was a gift from Sanofi-Aventis Deutsch-
land GmbH, former Hoechst AG (Frankfurt, Germany).
Mono-rhamnolipid standard (Rha-C10-C10) was prepared
as described before [67].
Rhamnolipid purification by adsorption
The medium was centrifuged in 200 mL cups for 60
min at 4,000 rpm (5810R Eppendorf AG, Hamburg,
Germany) to remove cells and cell debris. The cell-free
medium was loaded with five times the bed volume per
hour by a peristaltic pump (MP-3 Micro Tube Pump,
Eyela Inc., Tokyo, Japan) as specified by the manufac-
turer to a column packed with 90 g of conditioned
hydrophobic polymeric adsorbent (Amberlite XAD-2,
Sigma-Aldrich, St. Louis, MO, USA). After washing with
bidistilled water, rhamnolipids were eluted with 99% iso-
propanol using a continuous flow (HPLC pump 114 M,
Beckman Coulter, Inc., Brea, CA, USA). The organic
solvent was evaporated in a freeze dryer (Alpha I-5,
Martin Christ Gefriertrocknungsanlagen GmbH, Oster-
ode am Harz, Germany).
Theoretical capacity estimation
The flux balance analysis was carried out using the soft-
ware Insilico Discovery (version 3.2.0, Insilico Biotech-
nology AG, Stuttgart, Germany). The provided
metabolic network used for simulations was modified to
represent the reaction network of P. putida (Additional
file 1).
The following reactions were added to the P. putida
model:
α - D -Glucose - 1 - phosphate + NADPH + H+ + dTTP ⇒
dTDP - L - rhamnose + PPi + NADP
+ + H2O
(A)
2 β − 3− hydroxydecanoyl − ACP + H2O ⇔
β − 3− hydroxydecanoyl − β − 3− hydroxydecanote + 2ACP (B)
dTDP - L - rhamnose + β - 3 - hydroxydecanoyl - β - 3 - hydroxydecanoate ⇔
rhamnosyl - β - 3 - hydroxydecanoyl - β - 3 - hydroxydecanoate + dTDP
(C)
A linear optimization for rhamnolipid-production with
simultaneous minimization of total fluxes was carried
out. The rhamnolipid production rate was simulated
with different carbon substrates (glucose, glycerol,
sucrose, and octanoate). To ensure comparability of the
results, the unit Cmol, which normalizes the rhamnoli-
pid production rate to the amount of carbon atoms pre-
sent in the carbon substrate was chosen. The substrate
uptake was varied between 0 and 120 mCmol/(gCDW h).
The maintenance metabolism, characterized through the
simple reaction of ATP to ADP, was varied in the range
of 0 to 50 mmol/(gCDW h). Blank et al. [34] described a
value for the non-growth associated maintenance of
10.2 mmol ATP/(gCDW h) for P. putida DOT-T1E. The
considerably higher upper limit of 50 mmol ATP/(gCDW
h) accounts for scenarios of extra stress, e.g., for meta-
bolic cost of handling high rhamnolipid concentrations.
The chosen values for the growth rates were 0 1/h, 0.4
1/h and 0.8 1/h, reflecting ideal production condition,
growth observed during rhamnolipid production, and
maximal growth of P. putida on glucose [68]. Addition-
ally all occurring fluxes were limited to a maximal value
of 120 mCmol/(gCDW h). Furthermore, variation of the
fluxes through the pathways ED pathway, TCA cycle,
and PP pathway were examined. In addition, an alterna-
tive glucose uptake system, the phosphotransferase sys-
tem, and a complemented EMP pathway (insertion of a
phosphofructokinase reaction for example encoded on a
fructose utilization operon by fruK (PP0794), catalyzing
the conversion of glucose-6P to glucose-1,6P) were
simulated.
Determination of fermentation kinetics
The growth kinetic was described mathematically using
a logistic growth model. Logistic growth of pseudomo-
nads had been previously reported for rhamnolipid pro-
ducing wild type P. aeruginosa growing on sunflower oil
[55].
The biomass concentration X was described using
equation 1, where X0 is the initial biomass concentra-
tion, Xadd the additional biomass concentration, t0 the
time after which half of Xadd is formed, and b is a curve
form coefficient.
X(t) = X0 +
Xadd
1 +
(
t
t0
)b (1)
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The experimental data for the rhamnolipid and glu-
cose concentrations could be described with equations 2
and 3, where rRL is the specific rhamnolipid production
rate [grhamnolipid/(gCDW h)] and rGlucose is the specific
glucose uptake rate [gglucose/(gCDW h)].
dcRL
dt
= rRL · X (2)
dcGlu cos e
dt
= rGlu cos e · X (3)
A multivariable least squares fit was used to illustrate
the development of all three fermentation parameters
depending on each other.
Prior to utilizing the described procedure, to fit glu-
cose and rhamnolipid concentrations, two more
attempts applying different models were carried out
(Additional file 2).
Additional material
Additional file 1: Tabular presentation of the in silico reaction
network of Pseudomonas putida. A list of all reactions implemented in
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